Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient (API) Unit 1, located in ...

The near-term trigger for the stock is its plan to acquire Amplitude Surgical. Amplitude had a 5 per cent year-on-year (Y-o-Y ...

Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Discover how Zydus Wellness is reinventing Complan, the iconic health drink, by expanding its target audience, leveraging digital commerce, and strengthening its scientific credibility to stay ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

The purchase price is €6.25 per share of equity, putting the transaction value at €256.8 million for the 85.6% stake.

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

Regulatory News: Zydus Lifesciences Limited2 ("Zydus"), a global innovation-driven lifesciences company has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical’s ...